ASAH1 and nervous system disorder: Considering previous reports of increased LA, DHA and AA levels in the CSF of aSAH patients, but not in patients with other neurological diseases, such as meningitis or epilepsy, we speculate that the observed changes reflect aSAH-specific PUFA release [30].